Zanotti S - Search Results

1

Engineering an Environment for the Study of Fibrosis: A 3D Human Muscle Model with Endothelium Specificity and Endomysium.

Bersini S, Gilardi M, Ugolini GS, Sansoni V, Talò G, Perego S, Zanotti S, Ostano P, Mora M, Soncini M, Vanoni M, Lombardi G, Moretti M. Bersini S, et al. Among authors: zanotti s. Cell Rep. 2018 Dec 26;25(13):3858-3868.e4. doi: 10.1016/j.celrep.2018.11.092. Cell Rep. 2018. PMID: 30590054 Free article.

2

Decorin and biglycan expression is differentially altered in several muscular dystrophies.

Zanotti S, Negri T, Cappelletti C, Bernasconi P, Canioni E, Di Blasi C, Pegoraro E, Angelini C, Ciscato P, Prelle A, Mantegazza R, Morandi L, Mora M. Zanotti S, et al. Brain. 2005 Nov;128(Pt 11):2546-55. doi: 10.1093/brain/awh635. Epub 2005 Sep 23. Brain. 2005. PMID: 16183658

3

Proteoglycans are differentially altered in muscular dystrophies.

Zanotti S, Mora M. Zanotti S, et al. ScientificWorldJournal. 2006 Apr 4;6:446-8. doi: 10.1100/tsw.2006.88. ScientificWorldJournal. 2006. PMID: 16604255 Free PMC article. Review. No abstract available.

4

Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes.

Zanotti S, Saredi S, Ruggieri A, Fabbri M, Blasevich F, Romaggi S, Morandi L, Mora M. Zanotti S, et al. Matrix Biol. 2007 Oct;26(8):615-24. doi: 10.1016/j.matbio.2007.06.004. Epub 2007 Jun 27. Matrix Biol. 2007. PMID: 17662584

5

Fukutin gene mutations in an Italian patient with early onset muscular dystrophy but no central nervous system involvement.

Saredi S, Ruggieri A, Mottarelli E, Ardissone A, Zanotti S, Farina L, Morandi L, Mora M, Moroni I. Saredi S, et al. Among authors: zanotti s. Muscle Nerve. 2009 Jun;39(6):845-8. doi: 10.1002/mus.21271. Muscle Nerve. 2009. PMID: 19396839

6

Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment.

Zanotti S, Gibertini S, Mora M. Zanotti S, et al. Cell Tissue Res. 2010 Feb;339(2):397-410. doi: 10.1007/s00441-009-0889-4. Epub 2009 Nov 10. Cell Tissue Res. 2010. PMID: 19902258

7

Calsequestrin and junctin immunoreactivity in hexagonally cross-linked tubular arrays myopathy.

Di Blasi C, Blasevich F, Bellafiore E, Mottarelli E, Gibertini S, Zanotti S, Saredi S, Mantegazza R, Morandi L, Mora M. Di Blasi C, et al. Among authors: zanotti s. Neuromuscul Disord. 2010 May;20(5):326-9. doi: 10.1016/j.nmd.2010.02.003. Epub 2010 Mar 7. Neuromuscul Disord. 2010. PMID: 20211563

8

Fibroblasts from the muscles of Duchenne muscular dystrophy patients are resistant to cell detachment apoptosis.

Zanotti S, Gibertini S, Bragato C, Mantegazza R, Morandi L, Mora M. Zanotti S, et al. Exp Cell Res. 2011 Oct 15;317(17):2536-47. doi: 10.1016/j.yexcr.2011.08.004. Epub 2011 Aug 9. Exp Cell Res. 2011. PMID: 21851816

9

Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis.

Zanotti S, Gibertini S, Di Blasi C, Cappelletti C, Bernasconi P, Mantegazza R, Morandi L, Mora M. Zanotti S, et al. Histopathology. 2011 Dec;59(6):1215-28. doi: 10.1111/j.1365-2559.2011.04051.x. Histopathology. 2011. PMID: 22175901

10

Duchenne muscular dystrophy fibroblast nodules: a cell-based assay for screening anti-fibrotic agents.

Zanotti S, Gibertini S, Savadori P, Mantegazza R, Mora M. Zanotti S, et al. Cell Tissue Res. 2013 Jun;352(3):659-70. doi: 10.1007/s00441-013-1601-2. Epub 2013 Apr 5. Cell Tissue Res. 2013. PMID: 23552961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters